CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Yifan Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Yifan Pharmaceutical Co Ltd
No. 50
Qinshan, Jincheng Street, LinAn City
Phone: +86 55162672019p:+86 55162672019 HANGZHOU, ZHJ  311300  China Ticker: 002019002019
Business Summary
Yifan Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production, sales and pharmaceutical promotion services of pharmaceutical products, active pharmaceutical ingredient and polymer materials. The Company conducts business through two segments. The Pharmaceutical Products segment mainly produces Chinese patent medicines, chemical drugs and biological drugs. Its products include Child Qingqiao Granules, Skin Allery Relieving Capsules, lactulose oral solution and granulocyte colony stimulating factor. The Pharmaceutical Raw Materials and Polymers segment mainly produces active pharmaceutical ingredient, and its products are mainly vitamin B5 and pro-B5. The Company mainly conducts business in domestic and foreign markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2869 Industrial organic chemicals, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President XianfengCheng 55 1/1/2022 10/15/2014
Chief Financial Officer, Secretary of the Chairman DaweiZhang 42 7/10/2023 5/1/2021
Vice President, Secretary of the Board, Director DeqiFeng 44 5/6/2022 4/28/2016
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
SciGen Limited 152 Beach Road, The Gateway, # 26 07 08 Singapore

Business Names
Business Name
002019
1SciGen Australia Pty Ltd.
2SciGen India Pvt Ltd.
8 additional Business Names available in full report.

General Information
Number of Employees: 4,230 (As of 12/31/2023)
Outstanding Shares: 1,216,390,085 (As of 9/30/2024)
Shareholders: 38,911
Stock Exchange: SHE
Fax Number: +86 55162652019


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024